ReviewCurrent psychiatry reports2013
Psychopharmacology in psycho-oncology.
Review in Current psychiatry reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.
- Pharmacological interactions between psychotropic drugs and anticancer treatments: implications for clinical practice.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Pooled it
- Guideline
- Sexual Satisfaction in Psycho-Oncology Patients: Characteristics and Correlates.Psychiatry investigation · 2026Article
- Using GHQ-12 to Screen Mental Health Issues in People with Emphysema.Healthcare (Basel, Switzerland) · 2023Article
- Insomnia among Cancer Patients in the Real World: Optimising Treatments and Tailored Therapies.International journal of environmental research and public health · 2023Review
- Management of psychiatric disorders in patients with cancer.Indian journal of psychiatry · 2022Article
- Mental health care in oncology. Contemporary perspective on the psychosocial burden of cancer and evidence-based interventions.Epidemiology and psychiatric sciences · 2020Article
- Prevalence of Psychotropic Polypharmacy and Associated Healthcare Resource Utilization during Initial Phase of Care among Adults with Cancer in USA.Drugs - real world outcomes · 2019Article
- Article
- Feasibility of Psychosocial Distress Screening and Management Program for Hospitalized Cancer Patients.Psychiatry investigation · 2017Article
- Depressive Spectrum Disorders in Cancer: Diagnostic Issues and Intervention. A Critical Review.Current psychiatry reports · 2017Review
- Psychotropic drug dispensing in people with and without cancer in France.Journal of cancer survivorship : research and practice · 2017Article
- Advancing psychosocial care in cancer patients.F1000Research · 2017Review
- [Dyspnea, itching and depression in palliative medicine].Schmerz (Berlin, Germany) · 2016Article
- Management of delirium in palliative care: a review.Current psychiatry reports · 2015Review
- Psychopharmacology in cancer.Current psychiatry reports · 2015Review
- Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice.Neuropsychiatric disease and treatment · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Psychopharmacological intervention is a major clinical and research area in oncology and palliative care. Over the last 35 years, psychotropic drugs have been shown to have a number of important indications for the treatment of the most common psychiatric disorders, such as depression, anxiety, stress-related syndromes, severe adjustment disorders, sleep disorders and delirium, which combined affect at least 30-40% of patients with cancer and even a higher percentage of patients in an advanced phase of illness. The availability of new drugs, with less side-effects and safer pharmacological profiles, has been a major advance in clinical psycho-oncology. Interestingly, several drugs have also been found to be helpful for the adjuvant treatment of cancer-related symptoms, such as pain, hot flashes, pruritus, nausea and vomiting, fatigue, and cognitive impairment, making psychopharmacology an important tool for the improvement of cancer patients' quality of life. The aim of this paper is to summarize recent relevant data concerning the use of psychotropic drugs, namely antidepressants, anxiolytics, antipsychotics, anticonvulsants and psychostimulants in patients with cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.